BIOTRICITY INC. (BTCY) › Cash & EquivalentsBIOTRICITY INC. (BTCY) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $02013: $115.8K2014: $448.6K2015: $410.6K2016: $20.7K2017: $424.9K2018: $843.6K2019: $63.6K2020: $949.8K2021: $2.20M2022: $12.07M2023: $570.5K2024: $786.1K2025: $365.1K2026: $149.8K$149.8K2012Cash & Equivalents (USD)2026Fiscal YearCash & EquivalentsChange YoY2026$149.8K-59.0%2025$365.1K-53.5%2024$786.1K+37.8%2023$570.5K-95.3%2022$12.07M+448.1%2021$2.20M+131.8%2020$949.8K+1392.4%2019$63.6K-92.5%2018$843.6K+98.6%2017$424.9K+1956.6%2016$20.7K-95.0%2015$410.6K-8.5%2014$448.6K+287.5%2013$115.8K—2012$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share